Schwartz D H, Doherty P C
J Exp Med. 1982 Sep 1;156(3):810-21. doi: 10.1084/jem.156.3.810.
Thymocytes and spleen cells from C57BL/6 mice (H-2b) neonatally tolerized to H-2k alloantigens do not generate an anti-vaccinia response restricted to H-2Kk when adoptively transferred to appropriate irradiated hosts. This is in sharp contrast to the case for negatively selected C57BL/6 spleen cells acutely depleted of alloreactivity. No evidence for suppression was found in cell mixture experiments. We have shown elsewhere that our neonatally tolerized animals have a centrally induced delection-type tolerance in the absence of obvious suppression.2 We now suggest that in the neonatally tolerized mouse, chronic, central delection of anti-H-2k clones during early T cell ontogeny eliminates the major source of cells able to give rise, via somatic mutation and expansion, to anti-H-2Kk + vaccinia specific cytotoxic T lymphocyte precursors (CTL-P) in the adult. A similar mechanism may operate in the (k + b) leads to b chimera; however, the presence of H-2kxb accessory and presenting cells may permit the eventual generation (via cross-stimulation) of an H-2k-restricted vaccinia-specific repertoire. This would account for our observation of such "aberrant recognition" CTL-P emerging in the spleens of older (k x b) leads to b chimeras.
新生期经H-2k同种异体抗原耐受的C57BL/6小鼠(H-2b)的胸腺细胞和脾细胞,当被过继转移至适当的受照射宿主时,不会产生限于H-2Kk的抗痘苗反应。这与急性去除同种异体反应性的阴性选择的C57BL/6脾细胞的情况形成鲜明对比。在细胞混合实验中未发现抑制的证据。我们在其他地方已经表明,我们的新生期耐受动物在没有明显抑制的情况下具有中枢诱导的缺失型耐受。2我们现在认为,在新生期耐受的小鼠中,在早期T细胞个体发育过程中抗H-2k克隆的慢性中枢缺失消除了成年期能够通过体细胞突变和扩增产生抗H-2Kk +痘苗特异性细胞毒性T淋巴细胞前体(CTL-P)的主要细胞来源。类似的机制可能在(k + b)→b嵌合体中起作用;然而,H-2kxb辅助细胞和呈递细胞的存在可能允许最终产生(通过交叉刺激)H-2k限制的痘苗特异性库。这将解释我们在较老的(k×b)→b嵌合体脾脏中观察到的这种“异常识别”CTL-P的出现。